Abstract
The specific red cell adherence (SRCA) test used previously as a prognostic indicator of bladder tumors was used in a retrospective review of 14 patients with transitional cell carcinoma of the ureter and renal pelvis. SRCA-positive individuals appear to have better survival and progress less frequently to metastatic disease. Of five patients with positive reactions, none had distant metastases. Conversely, in SRCA-negative individuals metastatic disease developed more frequently (4 of 9). The SRCA test can be as useful a test of the prognosis of ureteral and renal pelvis tumors as it is of urinary bladder tumors.
| Original language | English |
|---|---|
| Pages (from-to) | 361-365 |
| Number of pages | 5 |
| Journal | Urology |
| Volume | 19 |
| Issue number | 4 |
| DOIs | |
| State | Published - 1982 |
Fingerprint
ASJC Scopus subject areas
- Urology
Cite this
Specific red cell adherence test applied to tumors of ureter and renal pelvis. / Gruber, M. B.; Becker, S. N.; Warren, M. M.; Rambo, M. J.; Davis, C. P.
In: Urology, Vol. 19, No. 4, 1982, p. 361-365.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Specific red cell adherence test applied to tumors of ureter and renal pelvis
AU - Gruber, M. B.
AU - Becker, S. N.
AU - Warren, M. M.
AU - Rambo, M. J.
AU - Davis, C. P.
PY - 1982
Y1 - 1982
N2 - The specific red cell adherence (SRCA) test used previously as a prognostic indicator of bladder tumors was used in a retrospective review of 14 patients with transitional cell carcinoma of the ureter and renal pelvis. SRCA-positive individuals appear to have better survival and progress less frequently to metastatic disease. Of five patients with positive reactions, none had distant metastases. Conversely, in SRCA-negative individuals metastatic disease developed more frequently (4 of 9). The SRCA test can be as useful a test of the prognosis of ureteral and renal pelvis tumors as it is of urinary bladder tumors.
AB - The specific red cell adherence (SRCA) test used previously as a prognostic indicator of bladder tumors was used in a retrospective review of 14 patients with transitional cell carcinoma of the ureter and renal pelvis. SRCA-positive individuals appear to have better survival and progress less frequently to metastatic disease. Of five patients with positive reactions, none had distant metastases. Conversely, in SRCA-negative individuals metastatic disease developed more frequently (4 of 9). The SRCA test can be as useful a test of the prognosis of ureteral and renal pelvis tumors as it is of urinary bladder tumors.
UR - http://www.scopus.com/inward/record.url?scp=0020070243&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020070243&partnerID=8YFLogxK
U2 - 10.1016/0090-4295(82)90189-3
DO - 10.1016/0090-4295(82)90189-3
M3 - Article
VL - 19
SP - 361
EP - 365
JO - Urology
JF - Urology
SN - 0090-4295
IS - 4
ER -